Role of RIP140 in metabolic tissues: Connections to disease

FEBS Letters

Volumn 582, Issue 1, 2008, Pages 39-45

  White, Roger ^a   Morganstein, Daniel ^a   Christian, Mark ^a   Seth, Asha ^a   Herzog, Birger ^a   Parker, Malcolm G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Coregulator; Metabolism; Nuclear receptor; PGC 1; RIP140

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PIOGLITAZONE; RECEPTOR INTERACTING PROTEIN 140; ROSIGLITAZONE;

DYSLIPIDEMIA; GENE; GENE TARGETING; HUMAN; METABOLIC DISORDER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RIP140 GENE; SHORT SURVEY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ENDOCRINE GLANDS; HUMANS; NUCLEAR PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 37349090082     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.11.017     Document Type: Short Survey

References (75)

1. Mangelsdorf DJ., et al. The nuclear receptor superfamily: the second decade. Cell 83 6 (1995) 835-839
2. Evans R.M. The nuclear receptor superfamily: a rosetta stone for physiology. Mol. Endocrinol. 19 6 (2005) 1429-1438
3. Robinson-Rechavi M., Escriva Garcia H., and Laudet V. The nuclear receptor superfamily. J. Cell Sci. 116 Pt 4 (2003) 585-586
4. Desvergne B., Michalik L., and Wahli W. Transcriptional regulation of metabolism. Physiol. Rev. 86 2 (2006) 465-514
5. Lin J., Handschin C., and Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1 6 (2005) 361-370
6. Leone T.C., et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 3 4 (2005) e101
7. Lelliott C.J., et al. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol. 4 11 (2006) e369
8. Feige J.N., and Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 17 6 (2007) 292-301
9. Handschin C., and Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 27 7 (2006) 728-735
10. Lin J., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119 1 (2004) 121-135
11. Jeong J.W., et al. The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism. Mol. Endocrinol. 20 5 (2006) 1138-1152
12. Picard F., et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111 7 (2002) 931-941
13. Louet, J.F. and W. O'Malley B. (2007) Coregulators in adipogenesis: what could we learn from the SRC (p160) coactivator family? Cell Cycle, 6 (20).
14. Wang Z., et al. Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance. Cell Metab. 3 2 (2006) 111-122
15. Leonardsson G., et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc. Natl. Acad. Sci. USA 101 22 (2004) 8437-8442
16. Cavailles V., et al. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 91 21 (1994) 10009-10013
17. Cavailles V., et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. Embo J. 14 15 (1995) 3741-3751
18. White R., et al. The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat. Med. 6 12 (2000) 1368-1374
19. Leonardsson G., et al. Embryo transfer experiments and ovarian transplantation identify the ovary as the only site in which nuclear receptor interacting protein 1/RIP140 action is crucial for female fertility. Endocrinology 143 2 (2002) 700-707
20. Seth A., et al. The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab. 6 3 (2007) 236-245
21. Katsanis N., et al. Localisation of receptor interacting protein 140 (RIP140) within 100 kb of D21S13 on 21q11, a gene-poor region of the human genome. Hum Genet. 102 2 (1998) 221-223
22. Nichol D., et al. RIP140 expression is stimulated by estrogen-related receptor alpha during adipogenesis. J. Biol. Chem. 281 43 (2006) 32140-32147
23. Thenot S., et al. Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol. Cell Endocrinol. 156 1-2 (1999) 85-93
24. Kerley J.S., et al. Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism. Biochem. Biophys. Res. Commun. 285 4 (2001) 969-975
25. Graham J.D., et al. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. Mol. Endocrinol. 19 11 (2005) 2713-2735
26. Lin R., et al. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol. Endocrinol. 16 6 (2002) 1243-1256
27. Augereau P., et al. Transcriptional regulation of the human NRIP1/RIP140 gene by estrogen is modulated by dioxin signalling. Mol. Pharmacol. 69 4 (2006) 1338-1346
28. Carroll J.S., et al. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38 11 (2006) 1289-1297
29. Jepsen K., et al. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102 6 (2000) 753-763
30. Fernandes I., et al. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol. Cell 11 1 (2003) 139-150
31. Treuter E., et al. A regulatory role for RIP140 in nuclear receptor activation. Mol. Endocrinol. 12 6 (1998) 864-881
32. Christian M., White R., and Parker M.G. Metabolic regulation by the nuclear receptor corepressor RIP140. Trends Endocrinol. Metab. 17 6 (2006) 243-250
33. Kumar M.B., Tarpey R.W., and Perdew G.H. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J. Biol. Chem. 274 32 (1999) 22155-22164
34. Castet A., et al. Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol. Endocrinol. 20 5 (2006) 1035-1047
35. Teyssier C., et al. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. Mol. Endocrinol. 17 2 (2003) 287-299
36. Herzog B., et al. The nuclear receptor cofactor RIP140 is required for the regulation of hepatic lipid and glucose metabolism by LXR. Mol. Endocrinol. 21 11 (2007) 2687-2697
37. Heery D.M., et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387 6634 (1997) 733-736
38. Wei L.N., Farooqui M., and Hu X. Ligand-dependent formation of retinoid receptors, receptor-interacting protein 140 (RIP140), and histone deacetylase complex is mediated by a novel receptor-interacting motif of RIP140. J. Biol. Chem. 276 19 (2001) 16107-16112
39. Jakobsson T., et al. Molecular basis for repression of liver X receptor-mediated gene transcription by receptor-interacting protein 140. Biochem. J. 405 1 (2007) 31-39
40. Heery D.M., et al. Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J. Biol. Chem. 276 9 (2001) 6695-6702
41. Moore J.M., et al. Quantitative proteomics of the thyroid hormone receptor-coregulator interactions. J. Biol. Chem. 279 26 (2004) 27584-27590
42. Tazawa H., et al. Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140. Mol. Cell Biol. 23 12 (2003) 4187-4198
43. Wei L.N., and Hu X. Receptor interacting protein 140 as a thyroid hormone-dependent, negative co-regulator for the induction of cellular retinoic acid binding protein I gene. Mol. Cell Endocrinol. 218 1-2 (2004) 39-48
44. Christian M., Tullet J.M., and Parker M.G. Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. J. Biol. Chem. 279 15 (2004) 15645-15651
45. Wei L.N., et al. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem. 275 52 (2000) 40782-40787
46. Gupta P., et al. Regulation of co-repressive activity of and HDAC recruitment to RIP140 by site-specific phosphorylation. Mol. Cell Proteomics 4 11 (2005) 1776-1784
47. Mostaqul Huq M.D., et al. Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation. Embo J. 25 21 (2006) 5094-5104
48. Huq M.D., et al. Vitamin B6 conjugation to nuclear corepressor RIP140 and its role in gene regulation. Nat. Chem. Biol. 3 3 (2007) 161-165
49. Vo N., Fjeld C., and Goodman R.H. Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol. Cell Biol. 21 18 (2001) 6181-6188
50. Castet A., et al. Multiple domains of the receptor-interacting protein 140 contribute to transcription inhibition. Nucleic Acids Res. 32 6 (2004) 1957-1966
51. Zhang Q., Piston D.W., and Goodman R.H. Regulation of corepressor function by nuclear NADH. Science 295 5561 (2002) 1895-1897
52. Fjeld C.C., Birdsong W.T., and Goodman R.H. Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc. Natl. Acad. Sci. USA 100 16 (2003) 9202-9207
53. Kumar V., et al. Transcription corepressor CtBP is an NAD(+)-regulated dehydrogenase. Mol. Cell 10 4 (2002) 857-869
54. Palming J., et al. The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction. J. Clin. Endocrinol. Metab. 92 6 (2007) 2346-2352
55. Gaikwad A., et al. In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue. J. Biol. Chem. 276 25 (2001) 22559-22564
56. Powelka A.M., et al. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J. Clin. Invest. 116 1 (2006) 125-136
57. Bassel-Duby R., and Olson E.N. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75 (2006) 19-37
58. Larsson L., et al. MHC composition and enzyme-histochemical and physiological properties of a novel fast-twitch motor unit type. Am. J. Physiol. 261 1 Pt 1 (1991) C93-C101
59. Cannon B., and Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84 1 (2004) 277-359
60. Lowell B.B., and Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 404 6778 (2000) 652-660
61. Debevec D., et al. RIP140 regulates expression of Uncoupling Protein 1 in adipocytes through specific PPAR isoforms and ERR{alpha}. Mol. Endocrinol. 21 7 (2007) 1581-1592
62. Wang Y.X., et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2 10 (2004) e294
63. Huss J.M., et al. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell Biol. 24 20 (2004) 9079-9091
64. Lin J., et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418 6899 (2002) 797-801
65. Baar K., et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. Faseb J. 16 14 (2002) 1879-1886
66. Arany Z., et al. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5 1 (2007) 35-46
67. Puigserver P., and Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24 1 (2003) 78-90
68. Han S.H., Quon M.J., and Koh K.K. Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-alpha activators. Hypertension 46 5 (2005) 1086-1092
69. Yki-Jarvinen H. Thiazolidinediones. N. Engl. J. Med. 351 11 (2004) 1106-1118
70. Bogacka I., et al. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54 5 (2005) 1392-1399
71. Tiraby C., et al. Acquirement of brown fat cell features by human white adipocytes. J. Biol. Chem. 278 35 (2003) 33370-33376
72. Fievet C., Fruchart J.C., and Staels B. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Curr. Opin. Pharmacol. 6 6 (2006) 606-614
73. Carascossa S., et al. Receptor-interacting protein 140 is a repressor of the androgen receptor activity. Mol. Endocrinol. 20 7 (2006) 1506-1518
74. Zhang Z., et al. Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. Mol. Endocrinol. 20 7 (2006) 1547-1561
75. Dammer E.B., Leon A., and Sewer M.B. Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nondepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3′,5′-monophosphate-dependent cytochrome P450c17 transcription rate. Mol. Endocrinol. 21 2 (2007) 415-438